TP53 and neoplasm: In addition to the cell autonomous effects of TP53 inactivation/dysfunction, compelling evidence suggests that TP53 missense mutants may not merely lose their tumor suppressive functions, but can also acquire new oncogenic properties through the activation of cell non-autonomous pathways.